Identification of Risk Genes Associated with Myocardial Infarction-Big Data Analysis and Literature Review

Cosmin Tirdea1, Sorin Hostiuc1, Horatiu Moldovan2,3

  • 1Department of Legal Medicine and Bioethics, Faculty of Stomatology, Carol Davila University of Medicine, 050474 Bucharest, Romania.

Insights

This study identified 28 genes linked to increased risk of acute myocardial infarction (AMI). Key genetic risk factors for AMI include lymphotoxin-a (LTA), LGALS2, LDLR, and APOA5.

Area of Science:

  • Cardiovascular Genetics
  • Genomics
  • Biomedical Research

Background:

  • Acute myocardial infarction (AMI) remains a leading global cause of death, with a significant annual mortality rate.
  • Genetic predisposition, indicated by family history, is a potent risk factor for cardiovascular disease.
  • Identifying genetic risk factors for AMI is crucial for understanding disease mechanisms and developing targeted interventions.

Purpose of the Study:

  • To compile and analyze existing literature on genes associated with acute myocardial infarction (AMI).
  • To identify specific genes that confer an increased risk for developing AMI through big data analysis.

Main Methods:

  • Conducted a big data analysis using keywords "myocardial infarction", "genes", "involvement", "association", and "risk" across PubMed, Scopus, and Web of Science.
  • Exported data from titles, abstracts, and keywords into an Excel spreadsheet for analysis.
  • Utilized VOSviewer v. 1.6.18 software for data visualization and analysis of gene associations.

Main Results:

  • Identified 28 genes significantly associated with an increased risk for AMI.
  • Highlighted key genes such as lymphotoxin-a (LTA), LGALS2, LDLR, and APOA5 as particularly important risk factors.
  • Correlated findings from big data analysis with existing review data on AMI genetic associations.

Conclusions:

  • A deeper understanding of the functional genomic circuits underlying AMI is essential for future research.
  • The identified genes provide potential targets for novel diagnostic and therapeutic strategies for AMI.
  • This comprehensive analysis contributes to the knowledge base of genetic factors influencing myocardial infarction risk.